Merit医疗系统 MMSI 深 沪
等待开盘 09-26 09:30:00 美东时间
81.00
-2.080
-2.50%
华盛通- 最 高83.03
- 今 开82.90
- 成交量 92.37万股
- 最 低 79.11
- 昨 收 83.08
- 总市值 47.97亿
- 52周最高 111.45
- 市盈率 静 39.95
- 换手率 1.56%
- 52周最低 79.11
- 委 比 76.17%
- 总股本 5921.91万
- 历史最高 111.45
- 量 比 1.28
- 振 幅 4.72%
- 历史最低 9.15
- 每 手 1
- 风险率 6.87%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Merit Medical Embosphere Microspheres Achieve CE Mark for Genicular Artery Embolisation to Treat Knee Osteoarthritis
Merit Medical Systems announced the expanded EU indication for Embosphere Microspheres in genicular artery embolisation (GAE) to treat knee osteoarthritis (OA). Knee OA is the most common joint affected, with 595 million people worldwide suffering from OA, driven by aging populations and lifestyle factors. GAE, performed by interventional radiologists, reduces blood flow to inflamed synovium, providing fast, lasting pain relief, improving joint f...
09-12 18:30
Earnings Preview: Cooper Companies
Cooper Companies (NYSE:COO) is set to give its latest quarterly earnings report...
08-26 23:01
First Patient Enrolled in Merit Medical’s WRAPSODY (WRAP) North America Registry
Merit Medical Systems, Inc. announced the enrollment of the first patient in the WRAP North America registry, a study designed to evaluate the real-world safety and effectiveness of the WRAPSODY® Cell-Impermeable Endoprosthesis (CIE). The registry aims to enroll up to 250 U.S. and Canadian patients on hemodialysis experiencing venous obstructions. The study will assess clinical outcomes over three years, with enrollment led by Dr. Omar Davis at B...
08-18 13:25
Merit Medical Launches the Prelude Wave Hydrophilic Sheath Introducer with SnapFix Technology
Merit Medical推出了Prelude Wave™ Hydrophilic Sheath Introducer，配备独特的SnapFix™技术，旨在提高经桡动脉介入手术的成功率，减少动脉痉挛和阻塞的风险。Prelude Wave™具有超滑涂层、低剖面设计以及改良的过渡设计，可降低手术并发症。SnapFix™技术提供了更强劲的粘合性能，获得医生的高度评价。Merit Medical持续创新，支持径向优先的手术方法，致力于为医疗专业人士和患者提供更优的治疗体验。.
08-07 13:25
9 Analysts Have This To Say About Merit Medical Systems
9 analysts have shared their evaluations of Merit Medical Systems (NASDAQ:MMSI)...
07-31 22:01
Barrington Research Maintains Outperform on Merit Medical Systems, Maintains $103 Price Target
Barrington Research analyst Michael Petusky maintains Merit Medical Systems (NASDAQ:MMSI) with a Outperform and maintains $103 price target.
07-31 20:07
Merit Medical Systems Raises FY2025 Adj EPS Guidance from $3.28-$3.41 to $3.52-$3.72 vs $3.34 Est; Raises FY2025 Sales Guidance from $1.480B-$1.501B to $1.495B-$1.507B vs $1.485B Est
Merit Medical Systems (NASDAQ:MMSI) raises FY2025 Adj EPS guidance from $3.28-$3.41 to $3.52-$3.72 vs $3.34 analyst estimate. Raises FY2025 sales outlook from $1.480 billion-$1.501 billion to $1.495 billion-$1.507
07-31 04:23
Merit Medical Names Martha Aronson As President And CEO
Fred Lampropoulos will continue to serve as Chairman of Merit's Board of DirectorsMerit announces preliminary unaudited revenue for the quarter ended June 30, 2025
07-08 04:06
Merit Medical Names Martha Aronson as New President and Chief Executive Officer
Merit Medical Systems announced the appointment of Martha Aronson as President and CEO, effective October 3, 2025, while Fred Lampropoulos will remain Chairman of the Board. The company also reported preliminary unaudited revenue of $380 to $384 million for the second quarter of 2025, an increase of 12-14% compared to the previous year.
07-07 20:05
Merit Medical Systems To Announce Second Quarter 2025 Results On July 30, 2025
Merit Medical Systems, Inc. will release its second-quarter 2025 financial results on July 30, 2025, after market close. The company will hold an investor conference call that day at 5:00 p.m. Eastern Time. Registration for the call and access to the live webcast can be done through specified links. Merit, founded in 1987, develops and distributes medical devices used in various healthcare procedures and operates globally with over 800 sales and ...
07-03 20:05
